Malaria vaccine CDC/NIIMALVAC-1
Alternative Names: CDC/NIIMALVAC-1; Malaria vaccine multistage and multivalentLatest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria